TY - JOUR
KW - Social stigma
KW - Mycobacterium leprae
KW - leprosy
KW - Disability
KW - diagnosis
AU - Suzuki K
AU - Akama T
AU - Kawashima A
AU - Yoshihara A
AU - Yotsu R
AU - Ishii N
AB - Leprosy has affected humans for millennia and remains an important health problem worldwide, as evidenced by nearly 250 000 new cases detected every year. It is a chronic infectious disorder, caused by Mycobacterium leprae, that primarily affects the skin and peripheral nerves. Recent advances in basic science have improved our knowledge of the disease. Variation in the cellular immune response is the basis of a range of clinical manifestations. The introduction of multidrug therapy has significantly contributed to a decrease in the prevalence of the disease. However, leprosy control activities, including monitoring and prevention programs, must be maintained.
BT - The Journal of Dermatology
DA - 02/2012
DO - 10.1111/j.1346-8138.2011.01370.x
IS - 2
J2 - J. Dermatol.
LA - eng
M1 - 2
N2 - Leprosy has affected humans for millennia and remains an important health problem worldwide, as evidenced by nearly 250 000 new cases detected every year. It is a chronic infectious disorder, caused by Mycobacterium leprae, that primarily affects the skin and peripheral nerves. Recent advances in basic science have improved our knowledge of the disease. Variation in the cellular immune response is the basis of a range of clinical manifestations. The introduction of multidrug therapy has significantly contributed to a decrease in the prevalence of the disease. However, leprosy control activities, including monitoring and prevention programs, must be maintained.
PB - Blackwell Publishing Ltd
PY - 2012
EP - 121–129
T2 - The Journal of Dermatology
TI - Current status of leprosy: Epidemiology, basic science and clinical perspectives
VL - 39
SN - 1346-8138
ER -